Jump to main content
eTG Complete
eTG Complete
Index
  1. Home
  2. Rheumatology
  3. Systemic vasculitides
  4. Kawasaki disease
  • Rheumatology
    • Assessment and initial management of musculoskeletal symptoms
    • Practical information on drugs used for musculoskeletal and rheumatological conditions
    • Adult-onset Still disease
    • Antiphospholipid syndrome
    • Autoinflammatory periodic fever syndromes
    • Back pain
    • Behçet syndrome
    • Crystal diseases including gout
    • Fibromyalgia
    • Idiopathic inflammatory myopathies
    • Immunoglobulin G4-related disease
    • Inflammatory connective tissue diseases
    • Juvenile idiopathic arthritis
    • Overview of limb conditions
    • Upper limb conditions
    • Lower limb conditions
    • Neck pain
    • Osteoarthritis
    • Musculoskeletal conditions in children and adolescents
    • Polymyalgia rheumatica
    • Pregnancy-related low back pain and pelvic pain
    • Raynaud phenomenon
    • Rheumatoid arthritis
    • Spondyloarthritis
    • Systemic vasculitides
      • Overview of systemic vasculitides
      • Giant cell arteritis
      • Takayasu arteritis
      • Kawasaki disease
        • Overview of Kawasaki disease
        • Diagnosis of Kawasaki disease
        • Management overview for Kawasaki disease
        • Intravenous immunoglobulin for management of Kawasaki disease
        • Low-dose aspirin for management of Kawasaki disease
        • High-dose aspirin for management of Kawasaki disease
        • Adjunctive management for high-risk Kawasaki disease
        • Immunomodulatory drugs for intravenous immunoglobulin-resistant Kawasaki disease
        • Follow-up for Kawasaki disease
        • References
      • Polyarteritis nodosa
      • ANCA-associated vasculitides
      • Immunoglobulin A vasculitis
      • Cryoglobulinaemia and cryoglobulinaemic vasculitis
    • Transition of adolescents to adult rheumatology management
    • Viral arthritis

Kawasaki disease

Published December 2024

  • Overview of Kawasaki disease
  • Diagnosis of Kawasaki disease
  • Management overview for Kawasaki disease
  • Intravenous immunoglobulin for management of Kawasaki disease
  • Low-dose aspirin for management of Kawasaki disease
  • High-dose aspirin for management of Kawasaki disease
  • Adjunctive management for high-risk Kawasaki disease
  • Immunomodulatory drugs for intravenous immunoglobulin-resistant Kawasaki disease
  • Follow-up for Kawasaki disease
  • Contact us
  • Conditions of use and disclaimer
  • Privacy policy
  • Copyright permission
  • Support and FAQ

www.tg.org.au
All site content © Therapeutic Guidelines Limited 2020. Therapeutic Guidelines Limited, Ground Floor, 473 Victoria Street, West Melbourne, Victoria 3003, Australia © Therapeutic Guidelines Ltd (eTG August 2020)

Created: No created attribute found. Modified: No revised attribute found. (HW Diagnostics)